Selective TRIF-Dependent Signaling by a Synthetic Toll-Like Receptor 4 Agonist
- 14 February 2012
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 5 (211), ra13
- https://doi.org/10.1126/scisignal.2001963
Abstract
In response to ligand binding to the Toll-like receptor 4 (TLR4) and myeloid differentiation-2 (MD-2) receptor complex, two major signaling pathways are activated that involve different adaptor proteins. One pathway depends on myeloid differentiation marker 88 (MyD88), which elicits proinflammatory responses, whereas the other depends on Toll–IL-1 receptor (TIR) domain–containing adaptor inducing interferon-β (TRIF), which elicits type I interferon production. Here, we showed that the TLR4 agonist and vaccine adjuvant CRX-547, a member of the aminoalkyl glucosaminide 4-phosphate (AGP) class of synthetic lipid A mimetics, displayed TRIF-selective signaling in human cells, which was dependent on a minor structural modification to the carboxyl bioisostere corresponding to the 1-phosphate group on most lipid A types. CRX-547 stimulated little or no activation of MyD88-dependent signaling molecules or cytokines, whereas its ability to activate the TRIF-dependent pathway was similar to that of a structurally related inflammatory AGP and of lipopolysaccharide from Salmonella minnesota. This TRIF-selective signaling response resulted in the production of substantially less of the proinflammatory mediators that are associated with MyD88 signaling, thereby potentially reducing toxicity and improving the therapeutic index of this synthetic TLR4 agonist and vaccine adjuvant.Keywords
This publication has 53 references indexed in Scilit:
- Mechanism of Impaired NLRP3 Inflammasome Priming by Monophosphoryl Lipid AScience Signaling, 2011
- Selective Activation of the p38 MAPK Pathway by Synthetic Monophosphoryl Lipid AJournal of Biological Chemistry, 2009
- The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complexNature, 2009
- Lipid A mimetics are potent adjuvants for an intranasal pneumonic plague vaccineVaccine, 2008
- The ‘Ethereal’ nature of TLR4 agonism and antagonism in the AGP class of lipid A mimeticsBioorganic & Medicinal Chemistry Letters, 2008
- Lys63-Linked Polyubiquitination of IRAK-1 Is Required for Interleukin-1 Receptor- and Toll-Like Receptor-Mediated NF-κB ActivationMolecular and Cellular Biology, 2008
- Agonists of Toll-Like Receptors 3, 4, 7, and 9 Are Candidates for Use as Adjuvants in an Outer Membrane Vaccine againstNeisseria meningitidisSerogroup BInfection and Immunity, 2007
- The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transductionProceedings of the National Academy of Sciences of the United States of America, 2006
- Lysines 128 and 132 Enable Lipopolysaccharide Binding to MD-2, Leading to Toll-like Receptor-4 Aggregation and Signal TransductionOnline Journal of Public Health Informatics, 2003
- Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling PathwayScience, 2003